International Psoriasis Council

Advancing Knowledge. Improving Care.

José-Manuel

Carrascosa Carrillo

,

MD, PhD

Head of Dermatology, Associate Professor of Dermatology
University Hospital Germans Trias í Pujol; Autonomous University of Barcelona
Badalona
,
Spain
Councilor Since: March 17, 2023
IPC Councilor
José-Manuel Carrascosa-Carrillo is the Head of the Department of Dermatology at the Hospital Universitario Germans Trias i Pujol, Universitat Autònoma de Barcelona, Spain. He has been an Associate Professor at the Universitat Autònoma de Barcelona since 2009. He earned his medical degree from the Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona, in 1991 and his PhD from the Universitat Autònoma de Barcelona in 2006. Dr. Carrascosa-Carrillo is directly responsible for the Psoriasis, Phototherapy/Photobiology, Contact Dermatitis, Eczema Department, and the Psoriasis Unit at the Hospital Universitario Germans Trias i Pujol.

Dr. Carrascosa-Carrillo has been the Principal Investigator/Clinical Investigator in more than 60 research projects/clinical trials, many of which were multinational and multicentre studies related to biological therapies in psoriasis and atopic dermatitis. He has authored or co-authored 214 articles in journals on dermatology or other medical specialties. He was the Editor-in-Chief of Actas Dermo-sifiliográficas from 2010 to 2014 and is currently a reviewer for several peer-reviewed journals, including the Journal of Investigative Dermatology, The Lancet, Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of Crohn’s and Colitis, Journal of Dermatological Science, and Biodrugs.

Dr. Carrascosa-Carrillo has been the Chairperson at more than 100 local and international meetings and has been invited to give more than 250 lectures (national/international) at conferences, symposia, and other events. He is the Chair of the Spanish Group of Psoriasis of the Spanish Academy of Dermatology, and Vice-President of the Academia Española de Dermatología y Venereología (AEDV), and a member of the board of the BIOBADADERM registry. Moreover, he has been a member of the scientific board of the Skin Inflammation & Psoriasis International Network (SPIN) since 2015 and was on the organizing committee of the 2019 and 2022 SPIN meetings in Paris.
Last Updated:
03/23/2023

Areas of Interest

Real-world evidence guidelines; therapeutic targets in psoriasis in different circumstances/subsets of patients; chronic infections; pregnancy; older patients; cancer; clinical trials

IPC Committees / Groups

Editorial Committee

Languages Spoken

Catalan, English, Spanish

Involvement with Other Organization(s)

I have participated as an extern clinical expert for the Servei Català de Salut ( CatSalut) during the evaluation/reimbursement process of new biologic/small molecules in psoriasis.

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026